{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T06:32:52Z","timestamp":1720679572065},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,7,26]],"date-time":"2012-07-26T00:00:00Z","timestamp":1343260800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1186\/1471-2369-13-64","type":"journal-article","created":{"date-parts":[[2012,7,26]],"date-time":"2012-07-26T16:58:28Z","timestamp":1343321908000},"source":"Crossref","is-referenced-by-count":7,"title":["Anti-glomerular basement membrane glomerulonephritis and thrombotic microangiopathy in first degree relatives; a case report"],"prefix":"10.1186","volume":"13","author":[{"given":"Thomas","family":"Idorn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lone","family":"Schejbel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Casper","family":"Rydahl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James Goya","family":"Heaf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen Riis","family":"J\u00f8lvig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie","family":"Bergstr\u00f8m","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Garred","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne-Lise","family":"Kamper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,7,26]]},"reference":[{"key":"287_CR1","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1038\/ki.1996.495","volume":"50","author":"WK Bolton","year":"1996","unstructured":"Bolton WK: Goodpasture\u2019s syndrome. Kidney Int. 1996, 50: 1753-1766. 10.1038\/ki.1996.495.","journal-title":"Kidney Int"},{"key":"287_CR2","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1046\/j.1523-1755.2003.00241.x","volume":"64","author":"CD Pusey","year":"2003","unstructured":"Pusey CD: Anti-glomerular basement membrane disease. Kidney Int. 2003, 64: 1535-1550. 10.1046\/j.1523-1755.2003.00241.x.","journal-title":"Kidney Int"},{"key":"287_CR3","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1046\/j.1523-1755.1999.00720.x","volume":"56","author":"RG Phelps","year":"1999","unstructured":"Phelps RG, Rees AJ: The HLA complex in Goodpasture\u2019s disease: a model for analyzing susceptibility to autoimmunity. Kidney Int. 1999, 56: 1638-1653. 10.1046\/j.1523-1755.1999.00720.x.","journal-title":"Kidney Int"},{"key":"287_CR4","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1016\/S0140-6736(78)90252-0","volume":"1","author":"AJ Rees","year":"1978","unstructured":"Rees AJ, Peters DK, Compston DA, Batchelor JR: Strong association between HLA-DRW2 and antibody-mediated Goodpasture\u2019s syndrome. Lancet. 1978, 1: 966-968.","journal-title":"Lancet"},{"key":"287_CR5","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1111\/j.1538-7836.2005.01436.x","volume":"3","author":"DR Terrell","year":"2005","unstructured":"Terrell DR, Williams LA, Vesely SK, Lammle B, Hovinga JA, George JN: The incidence of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: all patients, idiopathic patients, and patients with severe ADAMTS-13 deficiency. J Thromb Haemost. 2005, 3: 1432-1436. 10.1111\/j.1538-7836.2005.01436.x.","journal-title":"J Thromb Haemost"},{"key":"287_CR6","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.1007\/s00467-010-1555-5","volume":"25","author":"D Kavanagh","year":"2010","unstructured":"Kavanagh D, Goodship T: Genetics and complement in atypical HUS. Pediatr Nephrol. 2010, 25: 2431-2442. 10.1007\/s00467-010-1555-5.","journal-title":"Pediatr Nephrol"},{"key":"287_CR7","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1182\/blood-2009-05-221549","volume":"115","author":"I Moore","year":"2010","unstructured":"Moore I, Strain L, Pappworth I, Kavanagh D, Barlow PN, Herbert AP, et al: Association of factor H autoantibodies with deletions of CFHR1, CFHR3, CFHR4, and with mutations in CFH, CFI, CD46, and C3 in patients with atypical hemolytic uremic syndrome. Blood. 2010, 115: 379-387. 10.1182\/blood-2009-05-221549.","journal-title":"Blood"},{"key":"287_CR8","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1093\/ndt\/gfn652","volume":"24","author":"PF Zipfel","year":"2009","unstructured":"Zipfel PF, Smith RJ, Skerka C: Factor I and factor H deficiency in renal diseases: similar defects in the fluid phase have a different outcome at the surface of the glomerular basement membrane. Nephrol Dial Transplant. 2009, 24: 385-387.","journal-title":"Nephrol Dial Transplant"},{"key":"287_CR9","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1136\/jmg.2006.045328","volume":"44","author":"A Servais","year":"2007","unstructured":"Servais A, Fremeaux-Bacchi V, Lequintrec M, Salomon R, Blouin J, Knebelmann B, et al: Primary glomerulonephritis with isolated C3 deposits: a new entity which shares common genetic risk factors with haemolytic uraemic syndrome. J Med Genet. 2007, 44: 193-199.","journal-title":"J Med Genet"},{"key":"287_CR10","doi-asserted-by":"publisher","first-page":"6030","DOI":"10.1074\/jbc.275.8.6030","volume":"275","author":"DB Borza","year":"2000","unstructured":"Borza DB, Netzer KO, Leinonen A, Todd P, Cervera J, Saus J, et al: The goodpasture autoantigen. Identification of multiple cryptic epitopes on the NC1 domain of the alpha3(IV) collagen chain. J Biol Chem. 2000, 275: 6030-6037. 10.1074\/jbc.275.8.6030.","journal-title":"J Biol Chem"},{"key":"287_CR11","doi-asserted-by":"publisher","first-page":"3446","DOI":"10.1093\/ndt\/gfq437","volume":"25","author":"N Torok","year":"2010","unstructured":"Torok N, Niazi M, Al AY, Taleb M, Taji J, Assaly R: Thrombotic thrombocytopenic purpura associated with anti-glomerular basement membrane disease. Nephrol Dial Transplant. 2010, 25: 3446-3449. 10.1093\/ndt\/gfq437.","journal-title":"Nephrol Dial Transplant"},{"key":"287_CR12","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1007\/s00467-010-1446-9","volume":"25","author":"PF Zipfel","year":"2010","unstructured":"Zipfel PF, Mache C, Muller D, Licht C, Wigger M, Skerka C: DEAP-HUS: deficiency of CFHR plasma proteins and autoantibody-positive form of hemolytic uremic syndrome. Pediatr Nephrol. 2010, 25: 2009-2019. 10.1007\/s00467-010-1446-9.","journal-title":"Pediatr Nephrol"},{"key":"287_CR13","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1038\/ki.1990.72","volume":"37","author":"DR Jayne","year":"1990","unstructured":"Jayne DR, Marshall PD, Jones SJ, Lockwood CM: Autoantibodies to GBM and neutrophil cytoplasm in rapidly progressive glomerulonephritis. Kidney Int. 1990, 37: 965-970. 10.1038\/ki.1990.72.","journal-title":"Kidney Int"},{"key":"287_CR14","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1016\/j.molimm.2006.10.005","volume":"44","author":"SC Nilsson","year":"2007","unstructured":"Nilsson SC, Karpman D, Vaziri-Sani F, Kristoffersson AC, Salomon R, Provot F, et al: A mutation in factor I that is associated with atypical hemolytic uremic syndrome does not affect the function of factor I in complement regulation. Mol Immunol. 2007, 44: 1835-1844. 10.1016\/j.molimm.2006.10.005.","journal-title":"Mol Immunol"},{"key":"287_CR15","doi-asserted-by":"publisher","first-page":"3385","DOI":"10.1093\/hmg\/ddg363","volume":"12","author":"J Caprioli","year":"2003","unstructured":"Caprioli J, Castelletti F, Bucchioni S, Bettinaglio P, Bresin E, Pianetti G, et al: Complement factor H mutations and gene polymorphisms in haemolytic uraemic syndrome: the C-257T, the A2089G and the G2881T polymorphisms are strongly associated with the disease. Hum Mol Genet. 2003, 12: 3385-3395. 10.1093\/hmg\/ddg363.","journal-title":"Hum Mol Genet"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2369-13-64\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2369-13-64.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2369-13-64","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2369-13-64.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,23]],"date-time":"2019-01-23T03:39:20Z","timestamp":1548214760000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/1471-2369-13-64"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7,26]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["287"],"URL":"https:\/\/doi.org\/10.1186\/1471-2369-13-64","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,7,26]]},"article-number":"64"}}